The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.
Apoptotic cell signaling in cancer progression and therapy
Open accessAbstract
Apoptosis is a tightly regulated cell suicide program that plays an essential role in the development and maintenance of tissue homeostasis by eliminating unnecessary or harmful cells. Impairment of this native defense mechanism promotes aberrant cellular proliferation and the accumulation of genetic defects, ultimately resulting in tumorigenesis, and frequently confers drug resistance to cancer cells. The regulation of apoptosis at several levels is essential to maintain the delicate balance between cellular survival and death signaling that is required to prevent disease. Complex networks of signaling pathways act to promote or inhibit apoptosis in response to various cues. Apoptosis can be triggered by signals from within the cell, such as genotoxic stress, or by extrinsic signals, such as the binding of ligands to cell surface death receptors. Various upstream signaling pathways can modulate apoptosis by converging on, and thereby altering the activity of, common central control points within the apoptotic signaling pathways, which involve the BCL-2 family proteins, inhibitor of apoptosis (IAP) proteins, and FLICE-inhibitory protein (c-FLIP). This review highlights the role of these fundamental regulators of apoptosis in the context of both normal apoptotic signaling mechanisms and dysregulated apoptotic pathways that can render cancer cells resistant to cell death. In addition, therapeutic strategies aimed at modulating the activity of BCL-2 family proteins, IAPs, and c-FLIP for the targeted induction of apoptosis are briefly discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
c-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3β activity
Quintavalle, C., Incoronato, M., Puca, L., Acunzo, M., Zanca, C., Romano, G., Garofalo, M., Iaboni, M., Croce, C. M., & Condorelli, G. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.65 · Cited by 40
RetractedCorrection: c-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3β activity
Quintavalle, C., Incoronato, M., Puca, L., Acunzo, M., Zanca, C., Romano, G., Garofalo, M., Iaboni, M., Croce, C. M., & Condorelli, G. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.7 · Cited by 27
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
The BCL-2 protein family: opposing activities that mediate cell death
Youle, R. J., & Strasser, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2308 · Cited by 4,679
Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81589-5 · Cited by 3,626
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.150 · Cited by 3,399
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Two CD95 (APO‐1/Fas) signaling pathways
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K., Krammer, P. H., & Peter, M. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1675 · Cited by 3,000
Causes and consequences of microRNA dysregulation in cancer
Croce, C. M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2634 · Cited by 2,998
Inhibition of death receptor signals by cellular FLIP
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.-L., Schröter, M., Burns, K., Mattmann, C., et al. (1997) · Nature · doi:10.1038/40657 · Cited by 2,563
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Genomic instability — an evolving hallmark of cancer
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397
(2001) · PubMed · Cited by 2,381
The Bcl-2 apoptotic switch in cancer development and therapy
Adams, J. M., & Cory, S. (2007) · Oncogene · doi:10.1038/sj.onc.1210220 · Cited by 2,176
Slee, E. A., Harte, M. T., Kluck, R. M., Wolf, B. B., Casiano, C. A., Newmeyer, D. D., Wang, H.-G., Reed, J. C., Nicholson, D. W., Alnemri, E. S., et al. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.2.281 · Cited by 1,929
An Oncogene-Induced DNA Damage Model for Cancer Development
Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816
Involvement of the bcl -2 Gene in Human Follicular Lymphoma
Tsujimoto, Y., Cossman, J., Jaffe, E., & Croce, C. M. (1985) · Science · doi:10.1126/science.3874430 · Cited by 1,786
Chipuk, J. E., Moldoveanu, T., Llambi, F., Parsons, M. J., & Green, D. R. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.025 · Cited by 1,427
TNF-α Induces Two Distinct Caspase-8 Activation Pathways
Wang, L., Du, F., & Wang, X. (2008) · Cell · doi:10.1016/j.cell.2008.03.036 · Cited by 1,351
Overview of cell death signaling pathways
Jin, Z., & El-Deiry, W. S. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1508 · Cited by 1,326
Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., & Perucho, M. (1997) · Science · doi:10.1126/science.275.5302.967 · Cited by 1,326
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
The miR-34 family in cancer and apoptosis
Hermeking, H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.56 · Cited by 1,236
Kuwana, T., Bouchier-Hayes, L., Chipuk, J. E., Bonzon, C., Sullivan, B. A., Green, D. R., & Newmeyer, D. D. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.003 · Cited by 1,185
Apoptosis Initiated When BH3 Ligands Engage Multiple Bcl-2 Homologs, Not Bax or Bak
Willis, S. N., Fletcher, J. I., Kaufmann, T., van Delft, M. F., Chen, L., Czabotar, P. E., Ierino, H., Lee, E. F., Fairlie, W. D., Bouillet, P., et al. (2007) · Science · doi:10.1126/science.1133289 · Cited by 1,125
p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes
Bommer, G. T., Gerin, I., Feng, Y., Kaczorowski, A. J., Kuick, R., Love, R. E., Zhai, Y., Giordano, T. J., Qin, Z. S., Moore, B. B., et al. (2007) · Current Biology · doi:10.1016/j.cub.2007.06.068 · Cited by 1,123
Degterev, A., Boyce, M., & Yuan, J. (2003) · Oncogene · doi:10.1038/sj.onc.1207107 · Cited by 1,107
Cytoplasmic functions of the tumour suppressor p53
Green, D. R., & Kroemer, G. (2009) · Nature · doi:10.1038/nature07986 · Cited by 1,106
Caspases in apoptosis and beyond
Li, J., & Yuan, J. (2008) · Oncogene · doi:10.1038/onc.2008.297 · Cited by 1,090
Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Baud, V., & Karin, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2781 · Cited by 1,061
Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
Kang, M. H., & Reynolds, C. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0144 · Cited by 1,016
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
Davis, M. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900015y · Cited by 977
A Unified Model for Apical Caspase Activation
Boatright, K. M., Renatus, M., Scott, F. L., Sperandio, S., Shin, H., Pedersen, I. M., Ricci, J.-E., Edris, W. A., Sutherlin, D. P., Green, D. R., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00051-0 · Cited by 968
Control of mitochondrial apoptosis by the Bcl-2 family
Brunelle, J. K., & Letai, A. (2009) · Journal of Cell Science · doi:10.1242/jcs.031682 · Cited by 929
Bcl-2 family proteins and cancer
Yip, K. W., & Reed, J. C. (2008) · Oncogene · doi:10.1038/onc.2008.307 · Cited by 881
Caspase function in programmed cell death
Kumar, S. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402060 · Cited by 864
mir-29 regulates Mcl-1 protein expression and apoptosis
Mott, J. L., Kobayashi, S., Bronk, S. F., & Gores, G. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210436 · Cited by 834
Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family
Eckelman, B. P., Salvesen, G. S., & Scott, F. L. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400795 · Cited by 813
MiR-15a and miR-16-1 cluster functions in human leukemia
Calin, G. A., Cimmino, A., Fabbri, M., Ferracin, M., Wojcik, S. E., Shimizu, M., Taccioli, C., Zanesi, N., Garzon, R., Aqeilan, R. I., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800121105 · Cited by 808
Weaver, V. M., Lelièvre, S., Lakins, J. N., Chrenek, M. A., Jones, J. C. R., Giancotti, F., Werb, Z., & Bissell, M. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00125-3 · Cited by 793
IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer
Gyrd-Hansen, M., & Meier, P. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2889 · Cited by 790
Apoptosis and cancer: the genesis of a research field
Cotter, T. G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2663 · Cited by 758
Human Caspases: Activation, Specificity, and Regulation
Pop, C., & Salvesen, G. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800084200 · Cited by 754
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo
Shim, J.-H., Xiao, C., Paschal, A. E., Bailey, S. T., Rao, P., Hayden, M. S., Lee, K.-Y., Bussey, C., Steckel, M., Tanaka, N., et al. (2005) · Genes & Development · doi:10.1101/gad.1360605 · Cited by 738
Mechanisms of resistance to TRAIL-induced apoptosis in cancer
Zhang, L., & Fang, B. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700792 · Cited by 702
BAX activation is initiated at a novel interaction site
Gavathiotis, E., Suzuki, M., Davis, M. L., Pitter, K., Bird, G. H., Katz, S. G., Tu, H.-C., Kim, H., Cheng, E. H.-Y., Tjandra, N., et al. (2008) · Nature · doi:10.1038/nature07396 · Cited by 700
Life and death by death receptors
Guicciardi, M. E., & Gores, G. J. (2009) · The FASEB Journal · doi:10.1096/fj.08-111005 · Cited by 690
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Ji, Q., Hao, X., Zhang, M., Tang, W., Yang, M., Li, L., Xiang, D., DeSano, J. T., Bommer, G. T., Fan, D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006816 · Cited by 689
Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells
Chekulaeva, M., & Filipowicz, W. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.04.009 · Cited by 685
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives
Aqeilan, R. I., Calin, G. A., & Croce, C. M. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.69 · Cited by 648
Fulda, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24064 · Cited by 615
Stepwise Activation of BAX and BAK by tBID, BIM, and PUMA Initiates Mitochondrial Apoptosis
Kim, H., Tu, H.-C., Ren, D., Takeuchi, O., Jeffers, J. R., Zambetti, G. P., Hsieh, J. J.-D., & Cheng, E. H.-Y. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.030 · Cited by 600
Colombel, M. C., Symmans, W. F., de Medina, S. G. D., O’Toole, K., Chopin, D. K., Benson, M. C., Olsson, C. A., Korsmeyer, S. J., & Buttyan, R. (1993) · PubMed · Cited by 591
NF-κB Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor Signaling
Kreuz, S., Siegmund, D., Scheurich, P., & Wajant, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3964-3973.2001 · Cited by 583
c-FLIPL is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis
Chang, D. W. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf356 · Cited by 563
Effects of Microrna-29 on Apoptosis, Tumorigenicity, and Prognosis of Hepatocellular Carcinoma
Xiong, Y., Fang, J.-H., Yun, J.-P., Yang, J., Zhang, Y., Jia, W.-H., & Zhuang, S.-M. (2010) · Hepatology · doi:10.1002/hep.23380 · Cited by 563
Lovell, J. F., Billen, L. P., Bindner, S., Shamas-Din, A., Fradin, C., Leber, B., & Andrews, D. W. (2008) · Cell · doi:10.1016/j.cell.2008.11.010 · Cited by 563
IAP-targeted therapies for cancer
LaCasse, E. C., Mahoney, D. J., Cheung, H. H., Plenchette, S., Baird, S., & Korneluk, R. G. (2008) · Oncogene · doi:10.1038/onc.2008.302 · Cited by 524
Caspases and Kinases in a Death Grip
Kurokawa, M., & Kornbluth, S. (2009) · Cell · doi:10.1016/j.cell.2009.08.021 · Cited by 474
MicroRNA 29b functions in acute myeloid leukemia
Garzon, R., Heaphy, C. E. A., Havelange, V., Fabbri, M., Volinia, S., Tsao, T., Zanesi, N., Kornblau, S. M., Marcucci, G., Calin, G. A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-211938 · Cited by 459
The CASBAH: a searchable database of caspase substrates
Lüthi, A. U., & Martin, S. J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402103 · Cited by 437
BCL-2 Family Proteins: Critical Checkpoints of Apoptotic Cell Death
Danial, N. N. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1598 · Cited by 433
Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
Ji, Q., Hao, X., Meng, Y., Zhang, M., DeSano, J., Fan, D., & Xu, L. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-266 · Cited by 394
The Human Anti-apoptotic Proteins cIAP1 and cIAP2 Bind but Do Not Inhibit Caspases
Eckelman, B. P., & Salvesen, G. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510863200 · Cited by 391
The life of a cell: apoptosis regulation by the PI3K/PKB pathway
Duronio, V. (2008) · Biochemical Journal · doi:10.1042/bj20081056 · Cited by 390
Boldin, M. P., Mett, I. L., Varfolomeev, E. E., Chumakov, I., Shemer-Avni, Y., Camonis, J. H., & Wallach, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.387 · Cited by 387
Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM
Fontana, L., Fiori, M. E., Albini, S., Cifaldi, L., Giovinazzi, S., Forloni, M., Boldrini, R., Donfrancesco, A., Federici, V., Giacomini, P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002236 · Cited by 385
A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression
Roskelley, C. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80117-0 · Cited by 384
Survivin: A new target for anti-cancer therapy
Ryan, B. M., O’Donovan, N., & Duffy, M. J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.05.003 · Cited by 379
Embedded together: The life and death consequences of interaction of the Bcl-2 family with membranes
Leber, B., Lin, J., & Andrews, D. W. (2007) · Apoptosis · doi:10.1007/s10495-007-0746-4 · Cited by 378
Survivin and IAP proteins in cell-death mechanisms
Altieri, D. C. (2010) · Biochemical Journal · doi:10.1042/bj20100814 · Cited by 376
Caspase-3 Activation is a Critical Determinant of Genotoxic Stress-Induced Apoptosis
Mazumder, S., Plesca, D., & Almasan, A. (2008) · Apoptosis and Cancer · doi:10.1007/978-1-59745-339-4_2 · Cited by 371
Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis
Dewson, G., & Kluck, R. M. (2009) · Journal of Cell Science · doi:10.1242/jcs.038166 · Cited by 359
To Trigger Apoptosis, Bak Exposes Its BH3 Domain and Homodimerizes via BH3:Groove Interactions
Dewson, G., Kratina, T., Sim, H. W., Puthalakath, H., Adams, J. M., Colman, P. M., & Kluck, R. M. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.005 · Cited by 348
Bcl-2–family proteins and hematologic malignancies: history and future prospects
Reed, J. C. (2008) · Blood · doi:10.1182/blood-2007-09-078162 · Cited by 345
Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska, M., Moss, S. F., Krajewski, S., Song, K. B., Holt, P. R., & Reed, J. C. (1996) · PubMed · Cited by 321
A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene
Cole, K. A., Attiyeh, E. F., Mosse, Y. P., Laquaglia, M. J., Diskin, S. J., Brodeur, G. M., & Maris, J. M. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2102 · Cited by 316
Bcl-XL Inhibits Membrane Permeabilization by Competing with Bax
Billen, L. P., Kokoski, C. L., Lovell, J. F., Leber, B., & Andrews, D. W. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060147 · Cited by 314
Tagawa, H., Karnan, S., Suzuki, R., Matsuo, K., Zhang, X., Ota, A., Morishima, Y., Nakamura, S., & Seto, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208300 · Cited by 307
Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunities
Plati, J., Bucur, O., & Khosravi‐Far, R. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21707 · Cited by 293
Self-citationMehrotra, S., Languino, L. R., Raskett, C. M., Mercurio, A. M., Dohi, T., & Altieri, D. C. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.021 · Cited by 291
microRNAs: Master Regulators as Potential Therapeutics in Cancer
Garofalo, M., & Croce, C. M. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100517 · Cited by 291
c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis
Golks, A., Brenner, D., Fritsch, C., Krammer, P. H., & Lavrik, I. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414425200 · Cited by 282
Billen, L. P., Shamas-Din, A., & Andrews, D. W. (2008) · Oncogene · doi:10.1038/onc.2009.47 · Cited by 278
TRAIL receptor signalling and modulation: Are we on the right TRAIL?
Mahalingam, D., Szegezdi, E., Keane, M., Jong, S. D., & Samali, A. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.11.006 · Cited by 272
Kan, T., Sato, F., Ito, T., Matsumura, N., David, S., Cheng, Y., Agarwal, R., Paun, B. C., Jin, Z., Olaru, A. V., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.002 · Cited by 266
Role of the miR‐106b‐25 microRNA cluster in hepatocellular carcinoma
Li, Y., Tan, W., Neo, T. W. L., Aung, M. O., Wasser, S., Lim, S. G., & Tan, T. M. C. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01164.x · Cited by 255
Turley, E. A., Veiseh, M., Radisky, D. C., & Bissell, M. J. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1089 · Cited by 253
Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis
Engels, I. H., Stepczynska, A., Stroh, C., Lauber, K., Berg, C., Schwenzer, R., Wajant, H., Jänicke, R. U., Porter, A. G., Belka, C., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203824 · Cited by 252
MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes
Inomata, M., Tagawa, H., Guo, Y.-M., Kameoka, Y., Takahashi, N., & Sawada, K. (2009) · Blood · doi:10.1182/blood-2008-07-163907 · Cited by 249
Mitochondrial signaling in cell death via the Bcl-2 family
Leibowitz, B., & Yu, J. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.6.11392 · Cited by 247
Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas
Mestre-Escorihuela, C., Rubio-Moscardo, F., Richter, J. A., Siebert, R., Climent, J., Fresquet, V., Beltran, E., Agirre, X., Marugan, I., Marín, M., et al. (2007) · Blood · doi:10.1182/blood-2006-06-026500 · Cited by 246
Defining Characteristics of Types I and II Apoptotic Cells in Response to TRAIL
Özören, N., & El-Deiry, W. S. (2002) · Neoplasia · doi:10.1038/sj.neo.7900270 · Cited by 237
BH3-only proteins and their roles in programmed cell death
Giam, M., Huang, D. C. S., & Bouillet, P. (2008) · Oncogene · doi:10.1038/onc.2009.50 · Cited by 229
BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
Tu, Y., Renner, S., Xu, F., Fleishman, A. N., Taylor, J. M. G., Weisz, J., Vescio, R. A., Rettig, M. B., Berenson, J., Krajewski, S., et al. (1998) · PubMed · Cited by 222
XIAP as a ubiquitin ligase in cellular signaling
Galbán, S., & Duckett, C. S. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.81 · Cited by 215
Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models
Singh, M., Lima, A., Molina, R., Hamilton, P., Clermont, A. C., Devasthali, V., Thompson, J. D., Cheng, J. H., Bou Reslan, H., Ho, C. C. K., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1640 · Cited by 215
Death receptor signals to the mitochondria
Khosravi-Far, R. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.11.1173 · Cited by 214
Self-citationImoto, I., Yang, Z.-Q., Pimkhaokham, A., Tsuda, H., Shimada, Y., Imamura, M., Ohki, M., & Inazawa, J. (2001) · PubMed · Cited by 213
Expression and Genetic Analysis of XIAP-Associated Factor 1 (XAF1) in Cancer Cell Lines
Fong, W. G., Liston, P., Rajcan-Separovic, E., St. Jean, M., Craig, C., & Korneluk, R. G. (2000) · Genomics · doi:10.1006/geno.2000.6364 · Cited by 213
BCL2 Overexpression Associated With Chromosomal Amplification in Diffuse Large B-Cell Lymphoma
Monni, O., Joensuu, H., Franssila, K., Klefstrom, J., Alitalo, K., & Knuutila, S. (1997) · Blood · doi:10.1182/blood.v90.3.1168 · Cited by 212
Weaver, V. M., Bissell, M. J., Fischer, A. H., & Peterson, O. W. (1996) · Biochemistry and Cell Biology · doi:10.1139/o96-089 · Cited by 211
Abramson, J. S., & Shipp, M. A. (2005) · Blood · doi:10.1182/blood-2005-02-0687 · Cited by 208
Weaver, V. M., Lelièvre, S. A., Lakins, J. N., Chrenek, M. A., Jones, J., Giancotti, F. G., Werb, Z., & Bissell, M. J. (2002) · University of North Texas Digital Library (University of North Texas) · doi:10.1016/s1535-6108%2802%2900125-3 · Cited by 208
Evasion of Apoptosis as a Cellular Stress Response in Cancer
Fulda, S. (2010) · International Journal of Cell Biology · doi:10.1155/2010/370835 · Cited by 207
Mitochondria: pharmacological manipulation of cell death
Bouchier-Hayes, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26274 · Cited by 205
Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
Wilson, T., Johnston, P., & Longley, D. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909788166547 · Cited by 203
Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells
Gimenez-Bonafe, P., Tortosa, A., & Perez-Tomas, R. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909788166600 · Cited by 196
Caspase-8 in cancer biology and therapy
Fulda, S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.11.023 · Cited by 193
Gastrointestinal lymphoma: where morphology meets molecular biology
Isaacson, P. G., & Du, M. (2005) · The Journal of Pathology · doi:10.1002/path.1703 · Cited by 188
Meng, Y., Tang, W., Dai, Y., Wu, X., Liu, M., Ji, Q., Ji, M., Pienta, K., Lawrence, T., & Xu, L. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0333 · Cited by 185
The role of BH3-only protein Bim extends beyond inhibiting Bcl-2–like prosurvival proteins
Mérino, D., Giam, M., Hughes, P. D., Siggs, O. M., Heger, K., O'Reilly, L. A., Adams, J. M., Strasser, A., Lee, E. F., Fairlie, W. D., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200905153 · Cited by 185
Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy
Safa, A., Day, T., & Wu, C.-H. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908783497087 · Cited by 184
Tumors are unique organs defined by abnormal signaling and context
Radisky, D., Hagios, C., & Bissell, M. J. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0360 · Cited by 177
Molecular Details of Bax Activation, Oligomerization, and Membrane Insertion
Bleicken, S., Classen, M., Padmavathi, P. V. L., Ishikawa, T., Zeth, K., Steinhoff, H.-J., & Bordignon, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081539 · Cited by 176
Kruyt, F. A. E. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.003 · Cited by 172
Bagnoli, M., Canevari, S., & Mezzanzanica, D. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.015 · Cited by 170
MicroRNAs as gatekeepers of apoptosis
Subramanian, S., & Steer, C. J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22066 · Cited by 170
Gallenne, T., Gautier, F., Oliver, L., Hervouet, É., Noël, B., Hickman, J. A., Geneste, O., Cartron, P., Vallette, F. M., Manon, S., et al. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200809153 · Cited by 170
HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA
Fritsche, P., Seidler, B., Schüler, S., Schnieke, A., Göttlicher, M., Schmid, R. M., Saur, D., & Schneider, G. (2009) · Gut · doi:10.1136/gut.2009.180711 · Cited by 167
Mechanism of procaspase-8 activation by c-FLIP L
Yu, J. W., Jeffrey, P. D., & Shi, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812453106 · Cited by 162
Dai, Z. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg083 · Cited by 162
Compartmentalized Phosphorylation of IAP by Protein Kinase A Regulates Cytoprotection
Dohi, T., Xia, F., & Altieri, D. C. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.004 · Cited by 160
Song, J. H., Tse, M. C. L., Bellail, A., Phuphanich, S., Khuri, F., Kneteman, N. M., & Hao, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3896 · Cited by 160
Zhang, X., Jin, T. J., Yang, H., DeWolf, W. C., Khosravi‐Far, R., & Olumi, A. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1498 · Cited by 154
Self-citationAugello, C., Caruso, L., Maggioni, M., Donadon, M., Montorsi, M., Santambrogio, R., Torzilli, G., Vaira, V., Pellegrini, C., Roncalli, M. G., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-125 · Cited by 147
In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas
Mason, K. D., Vandenberg, C. J., Scott, C. L., Wei, A. H., Cory, S., Huang, D. C. S., & Roberts, A. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809957105 · Cited by 140
FLIP and the death effector domain family
Yu, J. W., & Shi, Y. (2008) · Oncogene · doi:10.1038/onc.2008.299 · Cited by 138
Castilla, C., Congregado, B., Chinchón, D., Torrubia, F., Japón, M. Á., & Sáez, C. (2006) · Endocrinology · doi:10.1210/en.2006-0502 · Cited by 133
Campana, D., Coustan‐Smith, E., Manabe, A., Buschle, M., Raimondi, S., Behm, F., Ashmun, R. A., Aricò, M., Biondi, A., & Pui, C. (1993) · Blood · doi:10.1182/blood.v81.4.1025.1025 · Cited by 127
Bitomsky, N., & Hofmann, T. G. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07331.x · Cited by 125
MicroRNAs as regulators of death receptors signaling
Garofalo, M., Condorelli, G. L., Croce, C. M., & Condorelli, G. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.105 · Cited by 122
Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma
Richter, J. Á., Robles, E. F., Fresquet, V., Beltrán, E., Rullan, A., Agirre, X., Calasanz, M. J., Panizo, C., Richter, J. Á., Hernández‐Rivas, J. M., et al. (2010) · Blood · doi:10.1182/blood-2010-02-268003 · Cited by 119
Bai, J., Sui, J., Demirjian, A. N., Vollmer, C. M., Marasco, W. A., & Callery, M. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3502 · Cited by 115
Ma, O., Cai, W., Zender, L., Dayaram, T., Shen, J., Herron, A. J., Lowe, S. W., Man, T., Lau, C. C., & Donehower, L. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2929 · Cited by 109
Sturm, I., Stephan, C., Gillissen, B. F., Siebert, R., Janz, M., Radetzki, S., Jung, K., Loening, S. A., Dörken, B., & Daniel, P. T. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401782 · Cited by 107
Jani, T. S., DeVecchio, J., Mazumdar, T., Agyeman, A., & Houghton, J. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091645 · Cited by 103
The role of Bcl-2 family proteins in chronic lymphocytic leukaemia
Buggins, A. G. S., & Pepper, C. J. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.03.011 · Cited by 101
Assembling the building blocks: structure and function of inhibitor of apoptosis proteins
Mace, P. D., Shirley, S., & Day, C. L. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.45 · Cited by 101
Werb, Z., Sympson, C. J., Alexander, C. M., et al. (1996) · PubMed · Cited by 99
IAP antagonists: promising candidates for cancer therapy
Mannhold, R., Fulda, S., & Carosati, E. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.003 · Cited by 98
Using Genetically Engineered Mouse Models of Cancer to Aid Drug Development: An Industry Perspective
Singh, M., & Johnson, L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0437 · Cited by 98
Pompéia, C., Hodge, D. R., Plass, C., Wu, Y.-Z., Márquez, V. E., Kelley, J. A., & Farrar, W. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3970 · Cited by 97
Schmeichel, K. L., Weaver, V. M., & Bissell, M. J. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018751124382 · Cited by 94
A tangled web of ubiquitin chains: breaking news in TNF-R1 signaling.
Bianchi, K., & Meier, P. (2009) · Molecules and Cells · doi:10.1016/j.molcel.2009.11.029 · Cited by 94
c-Fos as a Proapoptotic Agent in TRAIL-Induced Apoptosis in Prostate Cancer Cells
Zhang, X., Zhang, L., Yang, H., Huang, X., Otu, H. H., Libermann, T. A., DeWolf, W. C., Khosravi‐Far, R., & Olumi, A. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1310 · Cited by 93
Self-citationX-linked Inhibitor of Apoptosis: A Chemoresistance Factor or a Hollow Promise
Kashkar, H. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1664 · Cited by 91
Small-molecule pan-IAP antagonists: a patent review
Flygare, J. A., & Fairbrother, W. J. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903567077 · Cited by 91
Zantl, N., Weirich, G., Zall, H., Seiffert, B. M., Fischer, S. F., Kirschnek, S., Hartmann, C., Fritsch, R., Gillissen, B. F., Daniel, P. T., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210510 · Cited by 87
Crossing paths: interactions between the cell death machinery and growth factor survival signals
Brumatti, G., Salmanidis, M., & Ekert, P. G. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0288-8 · Cited by 85
Tumorigenicity of the miR-17-92 cluster distilled: Figure 1.Preprint
van Haaften, G. W., & Agami, R. (2010) · Genes & Development · doi:10.1101/gad.1887110 · Cited by 83
Role of bax Mutations in Apoptosis in Colorectal Cancers With Microsatellite Instability
Miquel, C., Borrini, F., Grandjouan, S., Auperin, A., Viguier, J., Velasco, V., Duvillard, P., Praz, F., & Sabourin, J. (2005) · American Journal of Clinical Pathology · doi:10.1309/jq2x-3rv3-l8f9-tgyw · Cited by 80
Olejniczak, E. T., Sant, C. V., Anderson, M. G., Wang, G. G., Tahir, S. K., Sauter, G., Lesniewski, R., & Semizarov, D. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0367 · Cited by 80
Weaver, V. M., & Bissell, M. J. (1999) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018781325716 · Cited by 79
Bcl-xL overexpression in human hepatocellular carcinoma
Watanabe, J., Kushihata, F., Honda, K., Mominoki, K., Matsuda, S., & Kobayashi, N. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.3.515 · Cited by 79
Okamoto, K., Fujisawa, J., Reth, M. G., & Yonehara, S. (2006) · Genes to Cells · doi:10.1111/j.1365-2443.2006.00927.x · Cited by 78
Kaposi's sarcoma tumor cells preferentially express Bcl-xL.
Foreman, K. E., Wrone-Smith, T., Boise, L., Thompson, C. B., Polverini, P. J., Simonian, P. L., Núñez, G., & Nickoloff, B. J. (1996) · Europe PMC (PubMed Central) · Cited by 72
Regulation of apoptosis: uncovering the binding determinants
Hinds, M. G., & Day, C. L. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.10.003 · Cited by 72
Hetschko, H., Voss, V., Horn, S., Seifert, V., Prehn, J. H. M., & Kögel, D. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9472-6 · Cited by 71
Guoan, X., Xiaomin, W., Hanning, W., Kai-yun, C., & Hao, L. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21408 · Cited by 71
Patel, M. P., Masood, A., Patel, P. S., & Chanan-Khan, A. A. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328331a7a4 · Cited by 69
Inhibitor of apoptosis proteins in hematological malignancies
Fulda, S. (2008) · Leukemia · doi:10.1038/leu.2008.329 · Cited by 67
BH3‐only proteins: The death‐puppeteer's wires
Ghiotto, F., Fais, F., & Bruno, S. (2009) · Cytometry Part A · doi:10.1002/cyto.a.20819 · Cited by 65
bcl-2 protein expression in melanocytic neoplasms of the skin.
Ramsay, J. A., From, L., & Kahn, H. J. (1995) · PubMed · Cited by 63
Baker, M. (2010) · Nature · doi:10.1038/4641225a · Cited by 62
Gao, S., Wang, H., Lee, P., Melamed, J., Li, C. X., Zhang, F., Wu, H., Zhou, L., & Wang, Z. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01991 · Cited by 61
Small Interfering RNA Targeting Bcl-2 Sensitizes Malignant Melanoma
Wacheck, V., Losert, D., Günsberg, P., Vornlocher, H., Hadwiger, P., Geick, A., Pehamberger, H., Müller, M., & Jansen, B. (2003) · Oligonucleotides · doi:10.1089/154545703322617078 · Cited by 58
Role ofbaxMutations in Apoptosis in Colorectal Cancers With Microsatellite Instability
Miquel, C., Borrini, F., Grandjouan, S., Auperin, A., Viguier, J., Velasco, V., Duvillard, P., Praz, F., & Sabourin, J. (2005) · American Journal of Clinical Pathology · doi:10.1309/jq2x3rv3l8f9tgyw · Cited by 55
Korkolopoulou, P. A., Saetta, A. A., Levidou, G., Gigelou, F., Lazaris, A. C., Thymara, I., Scliri, M., Bousboukea, K., Michalopoulos, N. V., Apostolikas, N., et al. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02723.x · Cited by 54
Expression of the Bcl-2 Protein BAD Promotes Prostate Cancer Growth
Smith, A. J., Karpova, Y., D'Agostino, R., Willingham, M. C., & Kulik, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006224 · Cited by 51
Wilson, T. R., Redmond, K. M., McLaughlin, K. M., Crawford, N., Gately, K. A., O'Byrne, K. J., Le-Clorrenec, C., Holohan, C., Fennell, D. A., Johnston, P. G., et al. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.76 · Cited by 48
Expression and biological significance of c-FLIP in human hepatocellular carcinomas
Du, X., Bao, G., He, X., Zhao, H., Yu, F., Qiao, Q., Lu, J., & Ma, Q.-J. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-24 · Cited by 47
Human skin equivalent as an alternative to animal testing.
Mertsching, H., Weimer, M., Kersen, S., & Brunner, H. (2008) · PubMed Central · Cited by 46
XIAP regulates bi-phasic NF-κB induction involving physical interaction and ubiquitination of MEKK2
Winsauer, G., Resch, U., Hofer-Warbinek, R., Schichl, Y. M., & de Martin, R. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.08.004 · Cited by 42
Modelling molecular mechanisms of breast cancer and invasion: lessons from the normal gland
Bissell, M. J. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350018 · Cited by 42
Targeting Inhibitor of Apoptosis Proteins (IAPs) for Cancer Therapy
Fulda, S. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008784533107 · Cited by 41
TRAIL induces proliferation of human glioma cells by c-FLIPL-mediated activation of ERK1/2
Vilimanovich, U., & Bumbaširević, V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7513-8 · Cited by 34
Letai, A. G. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200903134 · Cited by 33
Guillemin, Y., Lopez, J., Giménez, D., Fuertes, G., Valero, J. G., Blum, L. J., Gonzalo, P., Salgado, J., Girard-Egrot, A., & Aouacheria, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009066 · Cited by 32
Bcl-XL Small Interfering RNA Sensitizes Cisplatin-resistant Human Lung Adenocarcinoma Cells
Lei, X., Huang, Z., Zhong, M., Zhu, B., Tang, S., & Liao, D. (2007) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2007.00286.x · Cited by 27
Bcl-XL Protein Levels Determine Apoptotic Index in Pancreatic Carcinoma
Sharma, J., Srinivasan, R., Majumdar, S., Mir, S. S., Radotra, B. D., & Wig, J. D. (2005) · Pancreas · doi:10.1097/01.mpa.0000160282.64451.f1 · Cited by 24
Molecular targeted therapies for diffuse large B‐cell lymphoma based on apoptosis profiles
Cillessen, S. A. G. M., Meijer, C. J. L. M., Notoya, M., Ossenkoppele, G. J., & Oudejans, J. J. (2009) · The Journal of Pathology · doi:10.1002/path.2670 · Cited by 22
Phagocytosis of apoptotic cells by microglia in vitro
Bucur, O., Nat, R., Crețoiu, D., & Popescu, L. M. (2001) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2001.tb00181.x · Cited by 9
Self-citation
Cited by
Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics
Jan, R., & Chaudhry, G.-E.-S. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.024 · Cited by 899
Molecular Mechanisms of Apoptosis and Roles in Cancer Development and Treatment
Goldar, S., Khaniani, M. S., Derakhshan, S. M., & Baradaran, B. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.6.2129 · Cited by 606
Intrinsic and extrinsic pathways of apoptosis: Role in cancer development and prognosis
(2021) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2021.01.003 · Cited by 402
Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells
Muranen, T., Selfors, L. M., Worster, D. T., Iwanicki, M. P., Song, L., Morales, F. C., Gao, S., Mills, G. B., & Brugge, J. S. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.024 · Cited by 384
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
Neophytou, C. M., Trougakos, I. P., Erin, N., & Papageorgis, P. (2021) · Cancers · doi:10.3390/cancers13174363 · Cited by 371
Metadata
- Authors
- Plati, J., Bucur, O., & Khosravi-Far, R.
- Venue
- Integrative Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-22
- Volume
- 3
- Issue
- 4
- Pages
- 279-296
- ISSN
- 1757-9694 (ISSN-L)
- 1757-9708
- OpenAlex
- W2133575920
- Cited by
- 319
- References
- 193
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.